Mathematical model creation for cancer chemo-immunotherapy
From MaRDI portal
Publication:634409
Recommendations
- Mathematical modeling for tumor-immune interaction
- Modeling immunotherapy of the tumor -- immune interaction
- scientific article; zbMATH DE number 2062258
- Parameter estimation and sensitivity analysis for a model of tumor-immune interaction in the presence of immunotherapy and chemotherapy
- Studying the importance of regulatory T cells in chemoimmunotherapy mathematical modeling and proposing new approaches for developing a mathematical dynamic of cancer
Cited in
(58)- Understanding the interplay of CAR-NK cells and triple-negative breast cancer: insights from computational modeling
- A Mathematical Model of TCR-T Cell Therapy for Cervical Cancer
- scientific article; zbMATH DE number 7572510 (Why is no real title available?)
- The impact of radio-chemotherapy on tumour cells interaction with optimal control and sensitivity analysis
- Dynamic analysis of a drug resistance evolution model with nonlinear immune response
- Mathematical model for IL-2-based cancer immunotherapy
- Building mean field ODE models using the generalized linear chain trick \& Markov chain theory
- Modelling effects of a chemotherapeutic dose response on a stochastic tumour-immune model
- An extended mathematical model of tumor growth and its interaction with the immune system, to be used for developing an optimized immunotherapy treatment protocol
- Dynamics of tumor virotherapy: a deterministic and stochastic model approach
- An optimal control problem of immuno-chemotherapy in presence of gene therapy
- Study of dose-dependent combination immunotherapy using engineered T cells and IL-2 in cervical cancer
- Modeling the effects of space structure and combination therapies on phenotypic heterogeneity and drug resistance in solid tumors
- A stochastic individual-based model to explore the role of spatial interactions and antigen recognition in the immune response against solid tumours
- Studying the importance of regulatory T cells in chemoimmunotherapy mathematical modeling and proposing new approaches for developing a mathematical dynamic of cancer
- Role of regulatory T cells on a simple tumor-immune interaction system
- Comparative study for optimal control nonlinear variable-order fractional tumor model
- Mathematical modeling of tumor-immune system interactions: the effect of rituximab on breast cancer immune response
- Mathematical modelling for the role of CD\(4^+\)T cells in tumor-immune interactions
- On a multiobjective optimal control of a tumor growth model with immune response and drug therapies
- Thresholds for extinction and proliferation in a stochastic tumour-immune model with pulsed comprehensive therapy
- A mathematical model for chemoimmunotherapy of chronic lymphocytic leukemia
- Mathematical modeling and dynamic analysis of anti-tumor immune response
- Inferring the effect of therapies on tumor growth by using diffusion processes
- Modeling the effect of immunotherapies on human castration-resistant prostate cancer
- Maximization of viability time in a mathematical model of cancer therapy
- Therapy strategy in tumour cells and immune system interaction mathematical model
- A structural methodology for modeling immune-tumor interactions including pro- and anti-tumor factors for clinical applications
- Modeling the effects of chemotherapeutic dose response on a stochastic tumor-immune model of prostate cancer with androgen deprivation therapy
- Dynamics of tumor growth: chemotherapy and integrative oncology
- Model for acid-mediated tumour invasion with chemotherapy intervention. II: Spatially heterogeneous populations
- A mathematical model of cancer treatment by immunotherapy
- Parameter estimation and treatment optimization in a stochastic model for immunotherapy of cancer
- Mixed therapy in cancer treatment for personalized drug administration using model reference adaptive control
- Optimal treatment strategy for a tumor model under immune suppression
- Chemoimmunotherapy for the treatment of prostate cancer: insights from mathematical modelling
- Mathematical model of tumor-immune surveillance
- State-dependent impulsive control strategies for a tumor-immune model
- Enhancement of chemotherapy using oncolytic virotherapy: mathematical and optimal control analysis
- Diffusive tumor-immune interaction systems under immunotherapy
- Mathematical model of chimeric anti-gene receptor (CAR) T cell therapy with presence of cytokine
- Dynamic analysis of an antitumor model and investigation of the therapeutic effects for different treatment regimens
- Modeling cancer immunotherapy: assessing the effects of lymphocytes on cancer cell growth and motility
- MATHEMATICAL MODELING OF IN-VIVO TUMOR-IMMUNE INTERACTIONS FOR THE CANCER IMMUNOTHERAPY USING MATURED DENDRITIC CELLS
- Algorithmic asymptotic analysis: extending the arsenal of cancer immunology modeling
- Mathematical modelling and analysis of the tumor treatment regimens with pulsed immunotherapy and chemotherapy
- A mathematical study of the role of tbregs in breast cancer
- Cost-effectiveness analysis of optimal strategy for tumor treatment
- Control exponential growth of tumor cells with slow spread of oncolytic virus
- New observations on optimal cancer treatments for a fractional tumor growth model with and without singular kernel
- Mathematical modeling of mutant transferrin-CRM107 molecular conjugates for cancer therapy
- Modelling pulsed immunotherapy of tumour-immune interaction
- Inference on a stochastic two-compartment model in tumor growth
- Hopf bifurcation analysis in a delayed oncolytic virus dynamics with continuous control
- Mathematical modeling of tumor-immune cell interactions
- Tumor clearance analysis on a cancer chemo-immunotherapy mathematical model
- Mathematical analysis of a mathematical model of chemovirotherapy: effect of drug infusion method
- A NEW MATHEMATICAL MODELING AND SUB-OPTIMAL CHEMOTHERAPY OF CANCER
This page was built for publication: Mathematical model creation for cancer chemo-immunotherapy
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q634409)
